- Home
- JQC vs QURE Comparison
JQC vs QURE Comparison
Compare JQC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JQC
- QURE
- Stock Information
- Founded
- JQC 2003
- QURE 1998
- Country
- JQC United States
- QURE Netherlands
- Employees
- JQC N/A
- QURE N/A
- Industry
- JQC Finance Companies
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- JQC Finance
- QURE Health Care
- Exchange
- JQC Nasdaq
- QURE Nasdaq
- Market Cap
- JQC N/A
- QURE 725.4M
- IPO Year
- JQC N/A
- QURE 2007
- Fundamental
- Price
- JQC $5.24
- QURE $14.47
- Analyst Decision
- JQC
- QURE Strong Buy
- Analyst Count
- JQC 0
- QURE 10
- Target Price
- JQC N/A
- QURE $37.20
- AVG Volume (30 Days)
- JQC 714.6K
- QURE 2.1M
- Earning Date
- JQC 01-01-0001
- QURE 05-09-2025
- Dividend Yield
- JQC 11.13%
- QURE N/A
- EPS Growth
- JQC N/A
- QURE N/A
- EPS
- JQC N/A
- QURE N/A
- Revenue
- JQC N/A
- QURE $20,201,000.00
- Revenue This Year
- JQC N/A
- QURE $60.54
- Revenue Next Year
- JQC N/A
- QURE $183.28
- P/E Ratio
- JQC N/A
- QURE N/A
- Revenue Growth
- JQC N/A
- QURE 6.30
- 52 Week Low
- JQC $4.82
- QURE $3.73
- 52 Week High
- JQC $5.65
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- JQC 47.95
- QURE 53.75
- Support Level
- JQC $5.22
- QURE $14.81
- Resistance Level
- JQC $5.27
- QURE $16.20
- Average True Range (ATR)
- JQC 0.05
- QURE 0.94
- MACD
- JQC -0.01
- QURE 0.03
- Stochastic Oscillator
- JQC 17.65
- QURE 53.62
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.